NEW YORK (GenomeWeb) – Qiagen said today that it has signed two agreements that will expand the use of its bioinformatics solutions for microbiome, metagenomic, and other applications.
Specifically, the company is partnering with CosmosID to integrate that company's metagenomics analysis platform with Qiagen's CLC Genomics Workbench. The addition expands the range of metagenomic and microbiome applications supported by Qiagen's microbial genomics solution enabling researchers in fields such as infectious disease, animal health, agriculture, and environmental and food safety who use whole-genome shotgun metagenomics analysis for routine testing.
Qiagen has also contracted Trigent Solutions to provide its bioinformatics solutions to seven centers of the US Food and Drug Administration, where they will be used for infectious disease research and outbreak analysis. The list of software products that FDA centers will use includes CLC Genomics Workbench, CLC Microbial Genomics Module, CLC Genome Finishing Module, the Biomedical Genomics Workbench, Ingenuity Variant Analysis, and Ingenuity Pathway Analysis.
"We are excited about the latest agreements," Laura Furmanski, senior vice president and head of Qiagen's bioinformatics business area, said in a statement. "They are leveraging the reach and profile of our leading portfolio of bioinformatics solutions that enable a growing number of customers to analyze vast amounts of data from next-generation sequencing – and to arrive at actionable insights."